Home › Funds › Brooklands Fund Management Ltd › ELV
Brooklands Fund Management Ltd position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Brooklands Fund Management Ltd reported holding 12,760 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 0.63% of its reported portfolio and ranking #29 among its reported holdings. Brooklands Fund Management Ltd has disclosed ELV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-28 · Source: SEC EDGAR Form 13F-HR
How Brooklands Fund Management Ltd's ELV position evolved
Brooklands Fund Management Ltd first disclosed a stake in ELV in Q4 2024 at 14,796 shares (US$5.5M). The position peaked in Q4 2025 at 21,321 shares, worth US$7.4M. Across 8 filings, Brooklands Fund Management Ltd increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 12,760 shares valued at US$5.0M — an increase of 12,755 shares quarter over quarter.. Notable position changes include a 100% trim in Q3 2025 (shares rose 9% over the following quarter), a 710600% increase in Q4 2025 (shares fell 16% over the following quarter), a 255100% increase in Q3 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 14.80K | $5.45M | New |
| Q1 2025 | 16.80K | $7.30M | Add |
| Q2 2025 | 16.80K | $6.53M | Hold |
| Q3 2025 | 3 | $19.89K | Reduce |
| Q4 2025 | 21.32K | $7.38M | Add |
| Q1 2026 | 21.11K | $6.20M | Reduce |
| Q2 2026 | 5 | $48.39K | Reduce |
| Q3 2026 | 12.76K | $4.96M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on Brooklands Fund Management Ltd
FAQ
How long has Brooklands Fund Management Ltd held ELV?
Brooklands Fund Management Ltd has disclosed ELV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Brooklands Fund Management Ltd's current position in ELV?
As of Q3 2026, Brooklands Fund Management Ltd holds 12.76K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $4.96M, representing 0.63% of its reported portfolio and ranking #29.
Has Brooklands Fund Management Ltd been buying or selling ELV?
In the latest 13F filing (Q3 2026), Brooklands Fund Management Ltd increased its position in ELV. The position peaked in Q4 2025 at 21.32K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.